All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F12%3A10125073" target="_blank" >RIV/00179906:_____/12:10125073 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14740/12:00060118 RIV/00209805:_____/12:#0000342 RIV/00216208:11150/12:10125073

  • Result on the web

    <a href="http://www.translational-medicine.com/content/10/1/55" target="_blank" >http://www.translational-medicine.com/content/10/1/55</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/1479-5876-10-55" target="_blank" >10.1186/1479-5876-10-55</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

  • Original language description

    Background: There is no standard serum biomarker used for diagnosis or early detection of recurrence for renal cell carcinoma (RCC) patients. MicroRNAs (miRNAs) are abundant and highly stable in blood serum, and have been recently described as powerful circulating biomarkers in a wide range of solid cancers. Our aim was to identify miRNA signature that can distinguish the blood serum of RCC patients and matched healthy controls and validate identified miRNAs as potential biomarkers for RCC. Methods: Inthe screening phase of the study, blood serum of 15 RCC patients and 12 matched healthy controls were analyzed by use of the TaqMan Low-Density Arrays enabling parallel identification of expression levels of 667 miRNAs through qRT-PCR-based approach. Inthe validation phase, identified miRNAs were further evaluated on the independent group of 90 RCC patients and 35 matched healthy controls by use of individual qRT-PCR assays and statistically evaluated. Results: We identified 30 miRNAs d

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Translational Medicine

  • ISSN

    1479-5876

  • e-ISSN

  • Volume of the periodical

    10

  • Issue of the periodical within the volume

    22.3. 2012 (1)

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

  • UT code for WoS article

    000303352600001

  • EID of the result in the Scopus database